206 related articles for article (PubMed ID: 14614761)
1. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.
Morishita R; Kaneda Y; Ogihara T
BioDrugs; 2003; 17(6):383-9. PubMed ID: 14614761
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?
Morishita R; Aoki M; Kaneda Y
Curr Drug Targets; 2000 Jul; 1(1):15-23. PubMed ID: 11475534
[TBL] [Abstract][Full Text] [Related]
3. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.
Morishita R; Tomita N; Kaneda Y; Ogihara T
Curr Opin Pharmacol; 2004 Apr; 4(2):139-46. PubMed ID: 15063357
[TBL] [Abstract][Full Text] [Related]
4. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.
Morishita R; Aoki M; Kaneda Y
Ann N Y Acad Sci; 2001 Dec; 947():294-301; discussion 301-2. PubMed ID: 11795277
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases.
Tomita N; Ogihara T; Morishita R
Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):463-70. PubMed ID: 15030273
[TBL] [Abstract][Full Text] [Related]
6. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.
Morishita R; Higaki J; Tomita N; Ogihara T
Circ Res; 1998 Jun; 82(10):1023-8. PubMed ID: 9622154
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases.
Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
Curr Drug Targets; 2003 May; 4(4):339-46. PubMed ID: 12699354
[TBL] [Abstract][Full Text] [Related]
8. Potential therapeutic applications of decoy oligonucleotides.
Tomita N; Morishita R; Tomita T; Ogihara T
Curr Opin Mol Ther; 2002 Apr; 4(2):166-70. PubMed ID: 12044038
[TBL] [Abstract][Full Text] [Related]
9. [Oligonucleotide-based therapy as a potential new pharmacotherapy].
Morishita R
Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):123-30. PubMed ID: 10876797
[TBL] [Abstract][Full Text] [Related]
10. [Application of decoy strategy].
Morishita R; Ogihara T
Nihon Rinsho; 1996 Sep; 54(9):2583-90. PubMed ID: 8890596
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design.
Tomita N; Ogihara T; Morishita R
Curr Drug Targets; 2003 Nov; 4(8):603-8. PubMed ID: 14577649
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in gene therapy for cardiovascular disease.
Morishita R
Circ J; 2002 Dec; 66(12):1077-86. PubMed ID: 12499610
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy in vascular medicine: recent advances and future perspectives.
Morishita R; Aoki M; Kaneda Y; Ogihara T
Pharmacol Ther; 2001 Aug; 91(2):105-14. PubMed ID: 11728604
[TBL] [Abstract][Full Text] [Related]
14. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
Lavrovsky Y; Chen S; Roy AK
Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide-based gene therapy for cardiovascular disease.
Morishita R; Nakagami H; Taniyama Y; Matsushita H; Yamamoto K; Tomita N; Moriguchi A; Matsumoto K; Higaki J; Ogihara T
Clin Chem Lab Med; 1998 Aug; 36(8):529-34. PubMed ID: 9806454
[TBL] [Abstract][Full Text] [Related]
17. Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.
Tomita N; Tomita T; Yuyama K; Tougan T; Tajima T; Ogihara T; Morishita R
Curr Opin Mol Ther; 2003 Apr; 5(2):107-12. PubMed ID: 12772498
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases.
Tomita N; Morishita R
Curr Pharm Des; 2004; 10(7):797-803. PubMed ID: 15032704
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.
Tomita N; Kashihara N; Morishita R
Clin Exp Nephrol; 2007 Mar; 11(1):7-17. PubMed ID: 17384993
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
